Facebook
Twitter
LinkedIn
Forward
HVI Cardio-Oncology and Cardiac Imaging Symposium
This one-day CME event will feature a wide-range of topics on the rising specialty of cardio-oncology within the cardiology and oncology environments. Drawing on the expertise of the UPMC Center for Cardio-Oncology, this event aims to educate and provide knowledge to better care for patients with these conditions.
Target Audience
This course is designed for cardiologists (both invasive and non-invasive), cardiac surgeons, hematologists, oncologists and primary care providers as well as advanced practice providers, nurses, technologists, and other interested health care professionals.
Learning Objectives
- Improve knowledge regarding prevention and treatment of cardiovascular complications of cancer-related therapies.
- Understand the use of non-invasive imaging to prevent and detect cancer therapy related cardiac dysfunction.
- Develop a better understanding of diagnosis and treatment of cardiac amyloidosis, including the use of novel imaging techniques and new therapeutic treatment options.
- Improve knowledge regarding the role of echo in evaluating candidates and guiding therapy for structural heart interventions.
- Understand the use of microbubble contrast in the echo lab and potential future applications.
Additional Information
| Attachment | Size |
|---|---|
 T631-HVI Cardio-Oncology_Bro_2020_to_print_Approved.pdf | 979.45 KB |
| T638-HVI Cardio-Oncology_Handout_2020_0103_04 (approved).pdf | 1.3 MB |
HVI CARDIAC IMAGING SYMPOSIUM January 11, 2020 | ||
Agenda | ||
7:50-8:00 | Welcome and Introduction | Dr. Matthew Harinstein, Dr. William Katz, Dr. Flordeliza Villanueva |
8:10-8:55 | Keynote – “Developing and growing your cardio-oncology practice: It takes a village” | Dr. Jean-Bernard Durand (Director of Cardiomyopathy Services, MD Anderson Cancer Center) |
8:55-9:15 | Cardio-Oncology Guideline Document Overview | Dr. Matthew Harinstein |
9:15-9:35 | Use of Imaging in Cardio-Oncology | Dr. Joshua Levenson |
9:35-9:55 | Cardiomyopathy Prevention Strategies | Dr. Robin Girdhar |
9:55-10:15 | Break |
|
10:15-10:35 | Cardio-Oncology Consults Beyond Cardiomyopathy | Dr. Saul Silver |
10:35-10:55 | Surveillance of Survivors of Childhood Cancer | Dr. Kirsten Rose-Felker |
10:55-11:25 | Cardiac Amyloidosis: Novel Imaging Techniques and Overview | Dr. Prem Soman |
11:25-12:05 | Interesting Cardio-Oncology Case Presentations with Panel Discussion | Dr. Jean-Bernard Durand, Dr. Vikram Gorantla, Dr. Saul Silver, Dr. Roby Thomas, Dr. Kenneth Vesio |
12:05-12:50 | Lunch |
|
12:50-1:10 | Update on the Management of Hypertrophic Cardiomyopathy | Dr. Timothy Wong |
1:10-1:30 | Novel Use of Echo Contrast | Dr. Flordeliza Villanueva |
1:30-1:50 | Left Atrial Appendage Occluder Device Applications for Atrial Fibrillation | Dr. Samir Saba |
1:50-2:10 | Mitral Valve Anatomy and Echo Evaluation of Mitral Regurgitation | Dr. William Katz |
2:10-2:30 | Percutaneous Intervention for Mitral Regurgitation: Current and Future Options | Dr. A.J. Conrad Smith |
2:30 | Concluding Remarks | Dr. Matthew Harinstein, Dr. William Katz, Dr. Flordeliza Villanueva |
2:45 | Adjourn |
|
All individuals in a position to control the content of this educational activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
Vikram Gorantla, MD, is a consultant for Mylan and Integra.
Samir Saba, MD, receives grant/research support and is on the advisory board for Boston Scientific.
Prem Soman, MD, receives grant/research support from Astellas, Pfizer, Alnylam, and Ionis.
Timothy Wong, MD, receives grant/research support for clinical trials of mavacamten, Site PI EXPLORER-HCM, MAVERICK-HCM, and MAVA-LTE.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this educational activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this [replace with applicable format: live, enduring or blended] activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 5.75 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other Healthcare Professionals: Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 5.75 AAPA Category I CME
- 5.75 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 5.75 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 5.75 Attendance
We gratefully acknowledge the following companies for their support of this activity.
Exhibitors:
Abbott Structural Heart
Alnylam Pharmaceuticals
Amgen
AstraZeneca
Boston Scientific
Bracco Diagnostics Inc.
Bristol-Myers Squibb
GE Healthcare
Lantheus Medical Imaging
Pfizer Rare Disease
Philips Healthcare
Grants:
Alnylam Pharmaceuticals, Inc.
Bracco Diagnostics Inc.
Price
Registration is now Closed.
Registration Fees:
Physician Fee: $25
Other Health Care Professionals: $25
Students and Physicians in Training: $25
Registration fee includes:
• Continuing education credit
• Registration and course material
• Continental breakfast, refreshments, and lunch
Cancellation:
Cancellations must be in writing, via U.S. mail or fax. Tuition for cancellations postmarked or date stamped before December 28, 2019 will be completely refunded. No refunds will be issued after December 28, 2019.
Cancellation requests can be made to:
Courtney Sandrue
UPMC Heart and Vascular Institute 200 Lothrop St. 3rd Floor South Tower, WE354.1 Pittsburgh, PA 15213
Telephone: 412-647-5840 Fax: 412-647-4227 Email: [email protected]